Northwest Biotherapeutics, Inc. (NWBO)

OTCMKTS · Delayed Price · Currency is USD

0.2500

-0.0006 (-0.24%)

Oct 7, 2025, 3:59 PM EDT

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
Innovative Immunotherapies for Cancer	1.93M	Log In	Log In	Log In	Log In	Upgrade
Innovative Immunotherapies for Cancer Growth	14.80%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
United States, Germany, United Kingdom and Netherlands	1.93M	Log In	Log In	Log In	Log In	Upgrade
United States, Germany, United Kingdom and Netherlands Growth	14.80%	Log In	Log In	Log In	Log In	Upgrade